These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 38475849)

  • 21. Building and sustaining public and political commitment to the value of vaccination: Recommendations for the Immunization Agenda 2030 (Strategic Priority Area 2).
    Olayinka F; Sauer M; Menning L; Summers D; Wonodi C; Mackay S; MacDonald NE; Peter Figueroa J; Andriamitantsoa B; Bonsu G; Haldar P; Lindstrand A; Shimp L;
    Vaccine; 2024 Apr; 42 Suppl 1(Suppl 1):S43-S53. PubMed ID: 36528448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of donor funding for immunization from Gavi and other development assistance channels on vaccine coverage: Evidence from 120 low and middle income recipient countries.
    Ikilezi G; Augusto OJ; Dieleman JL; Sherr K; Lim SS
    Vaccine; 2020 Jan; 38(3):588-596. PubMed ID: 31679863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimating national, regional and provincial cost-effectiveness of introducing childhood 13-valent pneumococcal conjugate vaccination in China: a modelling analysis.
    Lai X; Garcia C; Wu D; Knoll MD; Zhang H; Xu T; Jing R; Yin Z; Wahl B; Fang H
    Lancet Reg Health West Pac; 2023 Mar; 32():100666. PubMed ID: 36785861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review of rotavirus vaccine use in Asia and the Pacific regions: challenges and future prospects.
    Buchy P; Chen J; Zhang XH; Benninghoff B; Lee C; Bibera GL
    Expert Rev Vaccines; 2021 Dec; 20(12):1499-1514. PubMed ID: 33275065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increasing immunization coverage.
    Hammer LD; Curry ES; Harlor AD; Laughlin JJ; Leeds AJ; Lessin HR; Rodgers CT; Granado-Villar DC; Brown JM; Cotton WH; Gaines BM; Gambon TB; Gitterman BA; Gorski PA; Kraft CA; Marino RV; Paz-Soldan GJ; Zind B; ;
    Pediatrics; 2010 Jun; 125(6):1295-304. PubMed ID: 20513736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global perspectives of determinants influencing HPV vaccine introduction and scale-up in low- and middle-income countries.
    Guillaume D; Waheed DE; Schleiff M; Muralidharan KK; Vorsters A; Limaye RJ
    PLoS One; 2024; 19(1):e0291990. PubMed ID: 38227567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How to address vaccine hesitancy? Lessons from National Hepatitis B Immunization Program in China.
    Jiang H; Wei C
    Front Public Health; 2024; 12():1286801. PubMed ID: 38317799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccine events raising public concern and associated immunization program policy and practice changes, China, 2005-2021.
    Liu X; Yu W; Yin Z; Rodewald L; Song Y; Zhang Z; Ye J; Li L; Cao L; Cao L
    Vaccine; 2022 Apr; 40(18):2561-2567. PubMed ID: 35339307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using big data to analyze the vaccination status of children with congenital heart disease in Yinzhou District, China.
    Zhang L; Yang Z; Yin Y; Huang W; Yi T; Ping J; Liu L; Shen P; Sun Y; Lin H
    Hum Vaccin Immunother; 2024 Dec; 20(1):2319967. PubMed ID: 38465660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
    Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
    Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The inception, achievements, and implications of the China GAVI Alliance Project on Hepatitis B Immunization.
    Kane MA; Hadler SC; Lee L; Shapiro CN; Cui F; Wang X; Kumar R
    Vaccine; 2013 Dec; 31 Suppl 9():J15-20. PubMed ID: 24331015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utilization pattern of Haemophilus influenza type b vaccine in eight provinces of China.
    Li Y; Yue C; Wang Y; Zhu X; Martin K; Scherpbier RW; Liu J; Wang Z; Ma Y; Cheng H; Zhang Z; Wang Q; Li H; Xie S; Xiao Q; Wang H; An Z
    Hum Vaccin Immunother; 2018 Apr; 14(4):894-899. PubMed ID: 29300680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccination.
    Clark A; Jauregui B; Griffiths U; Janusz CB; Bolaños-Sierra B; Hajjeh R; Andrus JK; Sanderson C
    Vaccine; 2013 Jul; 31 Suppl 3():C19-29. PubMed ID: 23777686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Status of New Vaccine Introduction - Worldwide, September 2016.
    Loharikar A; Dumolard L; Chu S; Hyde T; Goodman T; Mantel C
    MMWR Morb Mortal Wkly Rep; 2016 Oct; 65(41):1136-1140. PubMed ID: 27764083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccine-preventable disease control in the People's Republic of China: 1949-2016.
    Yu W; Lee LA; Liu Y; Scherpbier RW; Wen N; Zhang G; Zhu X; Ning G; Wang F; Li Y; Hao L; Zhang X; Wang H
    Vaccine; 2018 Dec; 36(52):8131-8137. PubMed ID: 30497834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful introduction of an underutilized elderly pneumococcal vaccine in a national immunization program by integrating the pre-existing public health infrastructure.
    Yang TU; Kim E; Park YJ; Kim D; Kwon YH; Shin JK; Park O
    Vaccine; 2016 Mar; 34(13):1623-1629. PubMed ID: 26850759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promoting immunization equity in Latin America and the Caribbean: Case studies, lessons learned, and their implication for COVID-19 vaccine equity.
    Chan IL; Mowson R; Alonso JP; Roberti J; Contreras M; Velandia-González M
    Vaccine; 2022 Mar; 40(13):1977-1986. PubMed ID: 35221122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
    Menzies R; Turnour C; Chiu C; McIntyre P
    Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Invasive bacterial diseases: national surveillance in Italy and vaccination coverage in the Local Health Agency 4 "Chiavarese", Liguria region (Italy).
    Trucchi C; Zoppi G
    J Prev Med Hyg; 2012 Jun; 53(2):120-4. PubMed ID: 23240174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Global Routine Vaccination Coverage, 2015.
    Casey RM; Dumolard L; Danovaro-Holliday MC; Gacic-Dobo M; Diallo MS; Hampton LM; Wallace AS
    MMWR Morb Mortal Wkly Rep; 2016 Nov; 65(45):1270-1273. PubMed ID: 27855146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.